EV-out or EV-in: Tackling cell-to-cell communication within the tumor microenvironment to enhance anti-tumor efficacy using extracellular vesicle-based therapeutic strategies

1. 15.

   Tumor-derived exosomes induce CD8+ T cell suppressors · 2017

2. 20.

   Organotropism: new insights into molecular mechanisms of breast cancer metastasis · 2018

3. 23.

   Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display · 2018

4. 26.

   Glioblastoma: Microenvironment and Niche Concept · 2018

5. 31.

   CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer · 2019

6. 34.

   Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy · 2019

7. 41.

   CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer · 2020

8. 42.

   Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source · 2020

9. 49.

   Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy · 2020

10. 58.

    Dexosomes as a cell-free vaccine for cancer immunotherapy · 2020

11. 64.

    Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes · 2021

12. 82.

    Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy? · 2021

13. 98.
    Corrected

    Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer · 2018

108 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.